These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29965856)

  • 1. The diagnostic work-up of cancer-associated myositis.
    Selva-O'Callaghan A; Martinez-Gómez X; Trallero-Araguás E; Pinal-Fernández I
    Curr Opin Rheumatol; 2018 Nov; 30(6):630-636. PubMed ID: 29965856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
    Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
    Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.
    Hida A; Yamashita T; Hosono Y; Inoue M; Kaida K; Kadoya M; Miwa Y; Yajima N; Maezawa R; Arai S; Kurasawa K; Ito K; Shimada H; Iwanami T; Sonoo M; Hatanaka Y; Murayama S; Uchibori A; Chiba A; Aizawa H; Momoo T; Nakae Y; Sakurai Y; Shiio Y; Hashida H; Yoshizawa T; Sakiyama Y; Oda A; Inoue K; Takeuchi S; Iwata NK; Date H; Masuda N; Mikata T; Motoyoshi Y; Uesaka Y; Maeda MH; Nakashima R; Tsuji S; Kwak S; Mimori T; Shimizu J
    Neurology; 2016 Jul; 87(3):299-308. PubMed ID: 27343066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignancy-associated myositis].
    Shimizu J
    Brain Nerve; 2010 Apr; 62(4):427-32. PubMed ID: 20420184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Cancer Screening in Myositis.
    Moghadam-Kia S; Oddis CV; Ascherman DP; Aggarwal R
    Rheum Dis Clin North Am; 2020 Aug; 46(3):565-576. PubMed ID: 32631604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for suspected myositis.
    Meyer A; Sibilia J
    Joint Bone Spine; 2019 Oct; 86(5):568-575. PubMed ID: 30711692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic inflammatory myopathies-a review.
    Jones J; Wortmann R
    Clin Rheumatol; 2015 May; 34(5):839-44. PubMed ID: 25681070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibody profile in myositis].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TIF1γ antibody and the expression of TIF1γ in idiopathic inflammatory myopathies.
    Kim Y; Song KS; Sohn EH; Kang SW; Yoo IS; Shim SC; Yoo SJ; Kim J
    Int J Rheum Dis; 2019 Feb; 22(2):314-320. PubMed ID: 30398003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights in myositis-specific autoantibodies.
    Ghirardello A; Doria A
    Curr Opin Rheumatol; 2018 Nov; 30(6):614-622. PubMed ID: 30234722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody].
    Szankai Z; Nagy-Vincze M; Bodoki L; Jakab A; Betteridge Z; Dankó K
    Orv Hetil; 2014 Sep; 155(36):1437-44. PubMed ID: 25176518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy and myositis: novel autoantibodies and new insights.
    Selva-O'Callaghan A; Trallero-Araguás E; Grau-Junyent JM; Labrador-Horrillo M
    Curr Opin Rheumatol; 2010 Nov; 22(6):627-32. PubMed ID: 20827204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of anti-nuclear matrix protein 2 antibody positive myopathy associated with lung cancer].
    Ohta S; Unoda K; Nakajima H; Ikeda S; Hamaguchi Y; Kimura F
    Rinsho Shinkeigaku; 2016 Aug; 56(8):573-6. PubMed ID: 27477574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic inflammatory muscle disease: clinical aspects.
    Rider LG; Miller FW
    Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):37-54. PubMed ID: 10882213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological subsets of juvenile idiopathic inflammatory myopathies--an update.
    Tansley SL; McHugh NJ
    Expert Rev Clin Immunol; 2016; 12(4):427-37. PubMed ID: 26651264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy screening in autoimmune myositis among Australian rheumatologists.
    Dutton K; Soden M
    Intern Med J; 2017 Dec; 47(12):1367-1375. PubMed ID: 28742270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays.
    Labrador-Horrillo M; Martínez MA; Selva-O'Callaghan A; Trallero-Araguás E; Balada E; Vilardell-Tarrés M; Juarez C
    Ann Rheum Dis; 2012 Jun; 71(6):993-6. PubMed ID: 22294626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.